MYUNGMOON Pharm co.,Ltd (KRX:017180)

MYUNGMOON Pharm co.,Ltd Revenue

MYUNGMOON Pharm co.,Ltd had revenue of 51.21B KRW in the quarter ending June 30, 2026, with 5.03% growth. This brings the company's revenue in the last twelve months to 199.82B, up 4.75% year-over-year. In the year 2025, MYUNGMOON Pharm co.,Ltd had annual revenue of 195.25B with 4.72% growth.

• Revenue (ttm): 199.82B
• Revenue Growth: +4.75%
• P/S Ratio: 0.21
• Revenue / Employee: 626.41M
• Employees: 319
• Market Cap: 41.85B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	195.25B	8.80B	4.72%
Dec 31, 2024	186.44B	16.88B	9.95%
Dec 31, 2023	169.57B	17.43B	11.46%
Dec 31, 2022	152.13B	14.38B	10.43%
Dec 31, 2021	137.76B	9.91B	7.75%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 18, 2026

Data Sources Report a data error